Results 251 to 260 of about 5,368,097 (298)

Reconsidering Control Logic and Translational Interpretation in TNEA‐Based Modulation of Hippocampal Oscillations

Advanced Science, EarlyView.
Changzhen Gong, Arthur Yin Fan
wiley   +1 more source

Blood-Based Biomarkers for Alzheimer Disease: Preventing Unintended Consequences. [PDF]

JAMA
Whitson HE, Fowler NR, Mielke MM.
europepmc   +1 more source

Cognitive and Brain Reserve as Modifiers of Early Alzheimer Disease-Related Cognitive Vulnerability. [PDF]

Neurology
Sewell KR, Solis-Urra P, Huang H, Karikari TK, Grove G, Kramer AF, McAuley E, Burns JM, Hillman CH, Vidoni ED, Morris JK, Marsland AL, Kang C, Sutton BP, Wan L, Kamboh MI, Gianaros PJ, Drake JA, Stern Y, Oberlin LE, Erickson KI.   +20 more
europepmc   +1 more source

Anemia and Blood Biomarkers of Alzheimer Disease in Dementia Development.

JAMA Netw Open
Valletta M, Vetrano DL, Qiu C, Canevelli M, Miccoli E, Andersson S, Fredolini C, Bruno G, Winblad B, Fratiglioni L, Grande G.   +10 more
europepmc   +1 more source

Days at Home Among Dually Eligible Medicare Beneficiaries With Alzheimer Disease and Related Dementias.

JAMA Netw Open
Zhang Y, Yang Y, Thunell J, Miller KEM.
europepmc   +1 more source

High-Level Alzheimer Disease Neuropathological Change Following Iatrogenic Exposure.

JAMA Neurol
Banerjee G, Mok TH, Hyare H, Cousins O, Jaunmuktane Z, Mead S, Collinge J.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Alzheimer's Disease

New England Journal of Medicine, 2010
Evidence-based, peer reviewed, best practice management guidelines for neurologists Diagnosis is only part of the puzzle. Effective treatment is what your patients really want. The European Federation of Neurological Societies has been publishing management guidelines in the European Journal of Neurology for many years.
Frank M LaFerla, Henry Querfurth
exaly   +8 more sources